Back to News
Market Impact: 0.65

Carlyle Secured Lending, Inc. (CGBD) Lags Q3 Earnings and Revenue Estimates

CGBDGBDC
Corporate EarningsAnalyst EstimatesCorporate Guidance & OutlookCompany FundamentalsAnalyst Insights
Carlyle Secured Lending, Inc. (CGBD) Lags Q3 Earnings and Revenue Estimates

Carlyle Secured Lending, Inc. (CGBD) reported Q3 earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.39, and revenues of $44.2 million, which also fell short of expectations by 5.68%. This financial underperformance contributes to the stock's year-to-date decline of 29.6%, significantly lagging the S&P 500's gains. With unfavorable estimate revisions, the company currently holds a Zacks Rank #4 (Sell), indicating expectations for continued underperformance within an industry already positioned in the bottom 22%.

Analysis

Carlyle Secured Lending, Inc. (CGBD) reported Q3 earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.39 per share by -2.56%. This performance marks a significant year-over-year decline from $0.49 per share and represents the company's second consecutive quarter missing EPS estimates, having surpassed consensus only once in the last four quarters. The company's Q3 revenues of $44.2 million also fell short of the Zacks Consensus Estimate by 5.68%, despite growing from $39.08 million in the prior year. CGBD's stock has severely underperformed the broader market, losing 29.6% year-to-date compared to the S&P 500's gain of 16.5%. The unfavorable trend in earnings estimate revisions ahead of this report resulted in a Zacks Rank #4 (Sell) for CGBD, signaling expected near-term underperformance. This outlook is further challenged by the Financial - SBIC & Commercial Industry's low ranking, positioned in the bottom 22% of all Zacks industries, suggesting broader sector headwinds impacting peers like Golub Capital BDC (GBDC) which also saw a 2.6% downward revision in its upcoming EPS estimates.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo